Human Genome Sciences Inc.
Human Genome Sciences Inc. (HGS), a pioneering biotechnology firm headquartered in the United States, has been at the forefront of genomic research since its establishment in 1992. With a strong focus on developing innovative therapies for serious diseases, HGS operates primarily in the fields of genomics and biopharmaceuticals.
The company is renowned for its unique approach to drug discovery, leveraging genomic data to create targeted treatments. Notable products include Benlysta, a groundbreaking therapy for lupus, which has solidified HGS's position in the biopharmaceutical market. Over the years, HGS has achieved significant milestones, including strategic partnerships and advancements in personalised medicine, further enhancing its reputation as a leader in the industry.
+62 vs industry average
Human Genome Sciences Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Human Genome Sciences Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Human Genome Sciences Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Human Genome Sciences Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Human Genome Sciences Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from GSK plc
Carbon Disclosure Project
Inherited from GSK plcThe Climate Pledge
Inherited from GSK plcUN Global Compact Climate Champions initiative
Inherited from GSK plcRE 100
Inherited from GSK plcClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project